These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30928187)

  • 1. Serum indoxyl sulfate predicts adverse cardiovascular events in patients with chronic kidney disease.
    Fan PC; Chang JC; Lin CN; Lee CC; Chen YT; Chu PH; Kou G; Lu YA; Yang CW; Chen YC
    J Formos Med Assoc; 2019 Jul; 118(7):1099-1106. PubMed ID: 30928187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between serum indoxyl sulfate levels with carotid-femoral pulse wave velocity in patients with chronic kidney disease.
    Wang SC; Lai YH; Liu CH; Wang CH; Hsu BG; Tsai JP
    Ren Fail; 2021 Dec; 43(1):796-802. PubMed ID: 33941031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease.
    Holle J; Querfeld U; Kirchner M; Anninos A; Okun J; Thurn-Valsassina D; Bayazit A; Niemirska A; Canpolat N; Bulut IK; Duzova A; Anarat A; Shroff R; Bilginer Y; Caliskan S; Candan C; Harambat J; Özcakar ZB; Soylemezoglu O; Tschumi S; Habbig S; Yilmaz E; Balat A; Zurowska A; Cakar N; Kranz B; Ertan P; Melk A; Azukaitis K; Schaefer F
    Pediatr Nephrol; 2019 Dec; 34(12):2571-2582. PubMed ID: 31428929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease.
    Lin CJ; Liu HL; Pan CF; Chuang CK; Jayakumar T; Wang TJ; Chen HH; Wu CJ
    Arch Med Res; 2012 Aug; 43(6):451-6. PubMed ID: 22885091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma indoxyl sulfate concentration predicts progression of chronic kidney disease in dogs and cats.
    Chen CN; Chou CC; Tsai PSJ; Lee YJ
    Vet J; 2018 Feb; 232():33-39. PubMed ID: 29428089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease.
    Kaminski TW; Pawlak K; Karbowska M; Znorko B; Mor AL; Mysliwiec M; Pawlak D
    Int Urol Nephrol; 2019 Mar; 51(3):491-502. PubMed ID: 30617956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease.
    Dou L; Poitevin S; Sallée M; Addi T; Gondouin B; McKay N; Denison MS; Jourde-Chiche N; Duval-Sabatier A; Cerini C; Brunet P; Dignat-George F; Burtey S
    Kidney Int; 2018 Apr; 93(4):986-999. PubMed ID: 29395338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum indoxyl sulfate is a useful predictor for progression of chronic kidney disease].
    Namba S; Okuda Y; Morimoto A; Kojima T; Morita T
    Rinsho Byori; 2010 May; 58(5):448-53. PubMed ID: 20560454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β
    Yamamoto S
    Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study.
    Rossi M; Campbell K; Johnson D; Stanton T; Pascoe E; Hawley C; Dimeski G; McWhinney B; Ungerer J; Isbel N
    Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):1035-42. PubMed ID: 24880738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil:lymphocyte ratio correlates with the uremic toxin indoxyl sulfate and predicts the risk of death in patients on hemodialysis.
    Lano G; Sallée M; Pelletier M; Bataille S; Fraisse M; McKay N; Brunet P; Dou L; Burtey S
    Nephrol Dial Transplant; 2022 Nov; 37(12):2528-2537. PubMed ID: 35146525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum total p-cresol and indoxyl sulfate correlated with stage of chronic kidney disease in renal transplant recipients.
    Huang ST; Shu KH; Cheng CH; Wu MJ; Yu TM; Chuang YW; Chen CH
    Transplant Proc; 2012 Apr; 44(3):621-4. PubMed ID: 22483453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of ABCG2 as an Exporter of Uremic Toxin Indoxyl Sulfate in Mice and as a Crucial Factor Influencing CKD Progression.
    Takada T; Yamamoto T; Matsuo H; Tan JK; Ooyama K; Sakiyama M; Miyata H; Yamanashi Y; Toyoda Y; Higashino T; Nakayama A; Nakashima A; Shinomiya N; Ichida K; Ooyama H; Fujimori S; Suzuki H
    Sci Rep; 2018 Jul; 8(1):11147. PubMed ID: 30042379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting protein-bound uremic toxins in chronic kidney disease.
    Niwa T
    Expert Opin Ther Targets; 2013 Nov; 17(11):1287-301. PubMed ID: 23941498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.
    Lin CJ; Wu V; Wu PC; Wu CJ
    PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New oral spherical carbon adsorbent effectively reduces serum indoxyl sulfate levels in moderate to advanced chronic kidney disease patients: a multicenter, prospective, open-label study.
    Kim SH; Jhee JH; Choi HY; Lee SH; Shin SK; Lee SY; Yang DH; Yi JH; Han SW; Jo YI; Park HC
    BMC Nephrol; 2020 Jul; 21(1):317. PubMed ID: 32736531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
    Niwa T
    Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on Indoxyl Sulfate-Review of Toxicity and Therapeutic Strategies. Toxins 2016, 8, 358.
    Barreto FC; Barreto DV; Stinghen AEM; Massy ZA
    Toxins (Basel); 2017 Apr; 9(4):. PubMed ID: 28420181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
    Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
    Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.